Sarepta therapeutics to announce fourth quarter and full-year 2024 financial results

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2024 financial results after the nasdaq global market closes on wednesday, feb. 26, 2025. subsequently, at 4:30 p.m. e.t., the company will host a conference call to discuss its fourth quarter and full-year 2024 financial results. the event will be webcast live under the investor relations section of sarepta's website a.
SRPT Ratings Summary
SRPT Quant Ranking